Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Depressive Disorders: Etiology

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

G-protein Coupled Receptors

G-protein Coupled Receptors

G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.

Depressive Disorders: MDD and Dysthymia

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...

Depression: Overview

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...

Antidepressant Drugs: Overview

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The 'hub' model for colorectal surgery: a viable paradigm shift?

Annals of the Royal College of Surgeons of England·2025

Same author

Cough-induced vertebral artery dissection: A case report and literature review.

The journal of the Royal College of Physicians of Edinburgh·2024

Same author

Level of polychlorinated biphenyls in tumor and blood serum of breast cancer patients and control subjects from Punjab, Pakistan.

The Science of the total environment·2024

Same author

Fabricating a 3D floating porous PDMS - Ag/AgBr decorated g-C<sub>3</sub>N<sub>4</sub> nanocomposite sponge as a re-usable visible light photocatalyst.

Scientific reports·2024

Same author

Diffusion-weighted imaging of the orbit.

Clinical radiology·2023

Same author

Role of Itolizumab in the Treatment of COVID-19 Patients, Admitted to ICU at a Tertiary Care Hospital.

The Journal of the Association of Physicians of India·2023

Search research articles

Related Experiment Video

Updated: Jun 1, 2026

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

Published on: August 11, 2021

Ect and platelet 5ht uptake in major depression.

P K Dalal¹, N Lal, J K Trivedi

¹P.K. DALAL, MD., Associate Professor, Department of Psychiatry, K.G'S Medical College, Lucknow-226003.

Indian Journal of Psychiatry

|May 18, 2011

Summary

This summary is machine-generated.

Major depression patients show reduced platelet serotonin (5-HT) uptake. Electroconvulsive therapy (ECT) temporarily increased this uptake, suggesting a link to the serotonergic system.

Keywords:

Active platelet 5-HT uptake ECT major depression serotonin

More Related Videos

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

Related Experiment Videos

Last Updated: Jun 1, 2026

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

Published on: August 11, 2021

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

Area of Science:

Neuroscience
Psychiatry
Biochemistry

Background:

Decreased platelet serotonin (5-HT) uptake is observed in major depressive disorder patients.
The precise antidepressant mechanism of electroconvulsive therapy (ECT) remains unclear.
The serotonergic system is implicated in mood regulation and antidepressant action.

Purpose of the Study:

To investigate active platelet 5-HT uptake in major depression.
To determine the effect of ECT on platelet 5-HT uptake in these patients.

Main Methods:

Study included 15 major depression patients (DSM-III-R) and 15 age/sex-matched controls.
Platelet 5-HT uptake was measured before, immediately after, and 1 week after a course of ECT.
Statistical analysis compared uptake levels between groups and across time points.

Main Results:

Platelet 5-HT uptake was significantly lower in major depression patients compared to controls.
ECT treatment led to a significant increase in platelet 5-HT uptake.
This elevated 5-HT uptake returned to pre-treatment levels one week after the final ECT session.

Conclusions:

ECT appears to modulate the serotonergic system in major depression patients.
The transient increase in platelet 5-HT uptake following ECT may contribute to its antidepressant effects.
Further research is warranted to fully elucidate ECT's impact on serotonergic neurotransmission.